Literature DB >> 21082875

Bilateral same-session ureteroscopy for treatment of ureteral calculi: critical analysis of risk factors.

Ahmed S El-Hefnawy1, Ahmed R El-Nahas, Nasr A El-Tabey, Ahmed M Shoma, Ahmed M El-Assmy, Mahmoud R El-Kenawy, Hamdy A El-Kappany, Ibrahim Eraky.   

Abstract

OBJECTIVE: To determine factors affecting the success of bilateral same-session ureteroscopy (BSU) in the treatment of ureteral calculi.
MATERIAL AND METHODS: From January 2003 to December 2008, BSU was carried out in 89 patients (178 renal units). A successful outcome was considered when both ureters were free of stones without intraoperative complications. Stone-free rate was evaluated with a kidney-ureter-bladder plain X-ray or non-contrast computed tomography. Factors interfering with successful completion of BSU were tested using univariate (chi-squared test and t test) and multivariate (logistic regression) analyses. Data on unilateral ureteroscopy for the treatment of multiple ureteral calculi carried out in 105 patients during the same period were compared with BSU.
RESULTS: Intraoperative complications were recorded in 11 procedures (6.2%) in the form of ureteral perforation in three and mucosal injury in eight. After BSU, 153 renal units were stone free (86%) as 17 had residual fragments, stones migrated to the kidney in six and failure was encountered in two. A successful outcome was observed in 62 patients (70%). Stone impaction, stones located in the proximal ureter and stone surface area were the significant risk factors for unsuccessful BSU (relative risks 3.6, 3.3 and 1.47, respectively). Compared with unilateral ureteroscopy, no difference were found with regard to complication rate (6.7%, p = 0.5) or stone-free rate (80%, p = 0.2).
CONCLUSIONS: Bilateral same-session ureteroscopy is a safe and effective procedure in the management of bilateral ureteral stones. Proximal ureteral calculi, large and impacted stones carry the highest risk of unsuccessful results.

Entities:  

Mesh:

Year:  2010        PMID: 21082875     DOI: 10.3109/00365599.2010.530612

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  8 in total

1.  Stones: Safety of bilateral same-session ureteroscopy.

Authors:  Katrina Ray
Journal:  Nat Rev Urol       Date:  2011-02       Impact factor: 14.432

2.  Bilateral same-session ureterorenoscopy: A feasible approach to treat pan-urinary stone disease.

Authors:  Bora Özveren; Murat Tugrul Eren; Hakan Özveri; Uğur Altuğ; Ahmet Şahin
Journal:  Arab J Urol       Date:  2017-10-09

Review 3.  Bilateral Simultaneous Ureteroscopic (BS-URS) Approach in the Management of Bilateral Urolithiasis Is a Safe and Effective Strategy in the Contemporary Era-Evidence from a Systematic Review.

Authors:  Robert M Geraghty; Bhavan P Rai; Patrick Jones; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2017-02       Impact factor: 3.092

4.  Bilateral same-session flexible ureterorenoscopy for renal and/or ureteric stone disease treatment.

Authors:  Ersan Arda; Basri Cakiroglu
Journal:  Arab J Urol       Date:  2018-05-18

5.  Bilateral same-session flexible ureteroscopy for renal stones: a feasible method.

Authors:  Bogdan Geavlete; Razvan-Ionut Popescu; Razvan Multescu; Valentin Iordache; Gelu-Adrian Popa; Dragos Georgescu; Petrisor Geavlete
Journal:  J Med Life       Date:  2022-02

6.  Feasibility and safety of bilateral same-session flexible ureteroscopy (FURS) for renal and ureteral stone disease.

Authors:  Tamsin Drake; Ahmed Ali; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2015-05-04

7.  Management of calcular anuria in adults caused by ureteric stones: By using of ureteroscopy and holmium laser.

Authors:  Mohammad S Abdel-Kader
Journal:  Arab J Urol       Date:  2011-11-17

8.  Risk factors for ureteroscopic lithotripsy: a case-control study and analysis of 385 cases of holmium laser ureterolithotripsy.

Authors:  Jiaxin Zheng; Yongfeng Wang; Bin Chen; Huiqiang Wang; Rongfu Liu; Bo Duan; Jinchun Xing
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-05-23       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.